| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Legal > Copyright > Safeguards for Copyrighted Collective Works |
|
Top Articles - Safeguards for Copyrighted Collective Works
Photographers often submit photos to publishers for inclusion in a book
or magazine. But what happens to the copyright for t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product hat photo? Does it
transfer to the publisher? What is the publisher allowed to do with the
copyright? Unless the copyrigh ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in t to a photo is specifically transferred in total to a
publisher, the publisher’s use of that photo is limited by the usage lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. agreement. The publisher, however, creates a new copyright, called a
“collective work,” when your photo is combined with ot here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe her photos, text,
illustrations, etc. Your photo then is covered by two copyrights – one for
the photo itself, and the oth d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro er as part of a collective work. As the owner of the copyright to a collective work, the publisher may reproduce and distri ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ute your contribution as part of that particular
collective work, but not as a separate item. The publisher also may
distr easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ibute any “revision” of that collective work and any later collective
work in the same series. "Revision" also is thought to nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically be a new
"version," which still is considered to be one work. Revision became an issue with some photographers who had c and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ntributed work for National Geographic magazine. There, National
Geographic distributed via CDs previously published magazin ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e issues
almost exactly as they appeared in print, except that National
Geographic added a search engine and index. The ph ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a otographers
argued it was a new use of their images and wanted to be paid for it.
National Geographic argued that the CDs dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ere a revision of the
collective work (the magazines) so that the usage was included in the
initial grant. Because the pho cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin tographers were located in different parts
of the United States, they filed their lawsuits in separate courts and both
cas tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen es were appealed. While the reasons why aren’t covered here, in
sum, the 2nd and 11th Circuit Court of Appeals came to diffe t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ent
conclusions about whether the CDs were a revision or a new product.
This inconsistency in the law will have to be reso ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust lved later. While hindsight is 20-20, we can learn from this experience that the best way to protect your copyrights is to y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products be as specific as possible when
granting usage rights. If you don’t want your photos used for certain
purposes, say so. Bu . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de if your agreement doesn’t address a usage, a
court that might not agree with your position just may be the one that
deter elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip mines your rights. Take my advice; get professional help. PhotoAttorney Copyright 2005 Carolyn E. Wright All Rights Reserve tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Guide to Selecting an Office Chair Seven Ways to Waste Your Money on Yellow Pages Advertising Compare Annuity Rate And Come Out On Top
|